Drawing for LIFE SAYS SCIENCE SAYS DIFFERENT

USPTO serial 86227485

LIFE SAYS SCIENCE SAYS DIFFERENT

Reviewed by CopyMark Law Group

Reg. 4824832Status 710
Filing date
Status date
Registration date
Oct 6, 2015
Examiner
GEARHART, DAVID JAMES
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with LIFE SAYS SCIENCE SAYS DIFFERENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Vanessa A. Ignacio

Vanessa A. Ignacio Lowenstein Sandler LLPOne Lowenstein Drivebayertrademarkus@bayer.comRoseland, NJ 07068

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry, science, agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticides; chemical seed treatment preparations; manuresSECTION 8 - CANCELLED—
003non-medicated skin care preparationsSECTION 8 - CANCELLED—
005pharmaceutical preparations used for the relief of pain and to reduce fever; pharmaceutical preparations and substances for the prevention and treatment of cardiovascular diseases, hemophilia, metabolic diseases, cancer, multiple sclerosis, urologic diseases, sexual dysfunction, osteoporosis, and climacteric diseases; pharmaceutical preparations, namely, anticoagulants and platelet aggregation inhibitors; contraceptive preparations, analgesics, anti-pyretics, anti-inflammatory preparations, anti-septic preparations, medicated lip balm, anesthetic spray for topical use, astringents, pediculicides, decongestants, antifungal agents, antiinfective pharmaceutical preparations, antacids, cold preparations in the nature of preparations for treating colds, menstrual symptom treatment preparations and dermatologicals; vitamin and mineral supplements; calcium supplements; medical diagnostic reagents for the analysis of body fluids; preparations used in medical diagnostic procedures, namely, contrast media for use with x-ray, magnetic resonance and ultrasound equipment; preparations for destroying vermin; insecticides; fungicides; herbicides; animal feed supplements; eye drops; medical reagents contained in cassettesSECTION 8 - CANCELLED—
009Computer software for managing a medical fluid delivery system and related accessories; computer software for monitoring, controlling and regulating the functions of a medical fluid delivery device; computer software and associated computer hardware for use in collecting, storing, managing, processing, communicating and reporting of data obtained from medical devices, medical related devices and input devices to which the hardware interconnects; computer software for use in monitoring, controlling and regulating the injection of medical fluids with a medical fluid delivery system; extravasation detection system comprised primarily of computer hardware and software for monitoring the injection of medical fluids; wireless communication network systems, namely, wireless access point (WAP) devices and associated computer hardware and software for wireless data delivery; wireless communication network systems, namely, wireless access point (WAP) devices and associated computer hardware and software for wireless data delivery all for use within a magnetic resonance imaging (MRI) suite or similar electromagnetically noisy environment; computer hardware and software used for diabetes monitoring and management; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricitySECTION 8 - CANCELLED—
010Medical diagnostic instruments for the analysis of body fluids; medical instruments, namely, injection systems containing of a vial adapter with a gauge needle attached for the application of medicines containing beta-interferon; medical devices for obtaining blood samples; medical instruments, namely, a self-contained reconstitution set for the reconstitution and subsequent injection of pharmaceutical compounds; medical devices for delivering measured amounts of solutions into the bloodstream over time; catheters; medical devices for use in diagnostic and therapeutic procedures, namely, radiological imaging and interventional treatments; disposable fluid path medical tubing for administration of fluids to a patient; syringes for medical purposes and for injections; computer controlled automatic injection system, namely, an automatic infusion system for injecting medical fluids during the process of diagnosis and treatment of a condition in an individual; medical fluid delivery systems consisting of injectors, infusion pumps, catheters, syringes and disposable fluid path tubing; probes for medical purposes; patient monitoring devices for use with magnetic resonance imaging apparatus, namely, vital signs monitors; medical devices, namely, anatomical positioning devices systems in the nature of medical devices for use in immobilizing internal organs, particularly the prostate, during medical procedures for use with magnetic resonance imaging (MRI); medical devices, namely, coils and interface devices in the nature of anatomically conformable surface coils for use with magnetic resonance imaging (MRI) systems; extravasation detection system for medical purposes comprised primarily of patient monitoring sensors, scan room and control room modules and sensor interface patchesSECTION 8 - CANCELLED—
031Agricultural, horticultural and forestry products and grains, namely, seeds for agricultural and horticultural purposes; foodstuffs for animalsSECTION 8 - CANCELLED—
037Repair and maintenance of medical devices; repair and maintenance services for vascular injection systems, Magnetic Resonance Imaging (MRI) coils and ultrasound transducersSECTION 8 - CANCELLED—
044Medical services; veterinary services; hygienic and beauty care for human beings and animalsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 22, 2022C8..CANCELLED SEC. 8 (6-YR)—
Oct 6, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 16, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 16, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 6, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 21, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 21, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 1, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 17, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 17, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 16, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Jun 16, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 16, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 16, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 16, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 16, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 8, 2015ALIEASSIGNED TO LIE—
Jun 1, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 8, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 3, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 3, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 3, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 4, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 4, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 4, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2014DOCKASSIGNED TO EXAMINER—
Apr 3, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 24, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance